Company / R&D per Share
Mettler Toledo R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$9.52
FY2025
5-year range
$6.13 / $9.52
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#2 of 108
Health Care
What the data says
Among 108 Health Care companies, Mettler Toledo is in the top 2% for r&d per share. R&D per Share has increased for 6 consecutive years, from $5.15 in FY2019 to $9.52 in FY2025.
Based on SEC 10-K filings.
9.52 in FY2025 with a 5-year CAGR of +10.2%. Ranks 2nd among 108 companies in Health Care.
Improved from $8.37 to $9.52 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- +10.2%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 108This company $9.52 Sector average $2.07
▼
+359.7% above sector average
Key checks
Key Insights
- Mettler Toledo's r&d per share has grown for 6 consecutive years.
- In FY2025, r&d per share increased 8.2% year-over-year.
- Ranks #2 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.52 | +8.2% |
| FY2024 | $8.80 | +5.1% |
| FY2023 | $8.37 | +36.5% |
| FY2022 | $6.13 | +0.0% |
| FY2021 | $6.13 | +4.9% |
| FY2020 | $5.85 | +13.6% |
| FY2019 | $5.15 | -5.9% |
| FY2018 | $5.47 | +12.6% |
| FY2017 | $4.86 | +10.2% |
| FY2016 | $4.41 | +4.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026